A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib

NCT04366713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2 Amplified Breast Cancer

Interventions

DRUG: Neratinib
DRUG: Capecitabine
DRUG: Loperamide

Sponsor

Puma Biotechnology, Inc.